Lapham, Kimberly
28  results:
Search for persons X
?
 
?
2

Improved PBPK model of carbamazepine as a strong CYP3A indu..:

Lin, Jian ; Lin, Zhiwu ; Johnson, Nathaniel..
Drug Metabolism and Pharmacokinetics.  55 (2024)  - p. 100885 , 2024
 
?
5

P100 - In vitro evaluation of UDP-glucuronosyltransferase (..:

Lapham, Kimberly ; Ferguson, Nicholas ; Novak, Jonathan..
Drug Metabolism and Pharmacokinetics.  35 (2020)  1 - p. S52-S53 , 2020
 
?
6

In vitro characterization of ertugliflozin glucuronidation:

Lapham, Kimberly ; Callegari, Ernesto ; Lin, Jian...
Drug Metabolism and Pharmacokinetics.  34 (2019)  1 - p. S24 , 2019
 
?
8

Industry standard UGT1A3 probe substrate CDCA: A second loo:

Novak, Jonathan J. ; Lin, Jian ; Riccardi, Keith..
Drug Metabolism and Pharmacokinetics.  33 (2018)  1 - p. S29-S30 , 2018
 
?
10

Enantioselective glucuronidation of lorazepam by UGT2B7 and..:

Lin, Jian ; Niosi, Mark ; Lapham, Kimberly..
Drug Metabolism and Pharmacokinetics.  33 (2018)  1 - p. S27 , 2018
 
?
12

Inhibition of Hepatobiliary Transport Activity by the Antib..:

Lapham, Kimberly ; Novak, Jonathan ; Marroquin, Lisa D....
Chemical Research in Toxicology.  29 (2016)  10 - p. 1778-1788 , 2016
 
?
15

Insights into the Novel Hydrolytic Mechanism of a Diethyl 2..:

Ryder, Tim ; Walker, Gregory S. ; Goosen, Theunis C....
Chemical Research in Toxicology.  25 (2012)  10 - p. 2138-2152 , 2012
 
1-15